Private VC-backed oncology biopharma company M&A transaction volumes 2019

M&A transaction volumes of private U.S. and European VC-backed oncology vs. non-oncology biopharma companies from 2010 to 2019 (in billion U.S. dollars)

US and European VC-backed oncology biopharma company M&A values 2010-2019

Last update:

Aug 19, 2020

Author:

��ƽ�� Research Department

Regions:

Europe, United States

Survey time period:

From 01/01/2010 to 31/12/2019

In 2019, the transaction volumes of private non-oncology biopharma companies reached 12.2 billion U.S. dollars, whereas the values for oncology companies were at 4.1 billion U.S. dollars. This statistic shows the M&A transaction volumes of private venture capital-backed oncology vs. non-oncology biopharma companies in U.S. and Europe from 2010 to 2019.

We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.

Get in touch

�����ƽ��

M&A transaction volumes of private U.S. and European VC-backed oncology vs. non-oncology biopharma companies from 2010 to 2019 (in billion U.S. dollars)

Get in touch with us for additional information

��ƽ��